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Abstract: Aim: This study aimed to assess the action of a chlorhexidine-based brush-on gel application
in the treatment of plaque-related gingivitis. Methods: The enrollment involved consecutive patients
diagnosed with plaque-induced gingivitis. Each participant’s full mouth plaque score and gingival
index were recorded at the first appointment (t0) and at follow ups after 1 week (t1), 2 weeks (t2) and
3 weeks (t4). All patients were randomly sorted into two groups: A study group, who was given
instruction to brush their gums daily with a chlorhexidine gel, and a control group who received
a placebo gel. The two groups’ data at baseline were compared using a chi-square test, while the
t-Student and Mann–Whitney tests were employed to analyze the index’s trends, both separately
and compared. Results: In total, 30 patients were enrolled, 15 referring to the study group and
15 to the control group. The study group had an 87% decrease in their plaque score and an 84%
decrease in their gingival index (p < 0.05). The control group displayed a reduction in plaque score
and gingival index of 74% and 84%, respectively (p < 0.05). The plaque score decreased statistically
more significantly in the study group than in the control group. Conclusion: Topical employment
of a chlorhexidine-containing brush-on gel appears to be a useful home tool in the treatment of
plaque-induced gingivitis, associated with professional debridement.
Keywords: gingivitis; chlorhexidine; oral hygiene; topical gel
1. Introduction
Dental plaque-associated gingivitis is the most common periodontal disease, with a prevalence
of 30–54% [1,2]. This gingival inflammatory condition is triggered by bacteria accumulation, and it
is characterized by clinical features such as swollen, tender, erythematous and bleeding gums,
halitosis and pain. The inflammation is found from the free attached gingiva to the mucogingival
junction, and according to the number of sites involved it can be classified as incipient, localized or
generalized [3]. This is a reversible disease that can lead to a restitutio ad integrum or evolve
into periodontitis, depending on the removal of the main etiological factor: the bacterial biofilm.
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Periodontitis is a chronic irreversible degenerative disease, involving the periodontal connective
tissues and the bone, and inducing teeth attachment loss [4,5]. Even though dental plaque is the
necessary key factor for gingivitis development, the severity of the disease is also related to oral and
systemic conditions, such as hormones, pharmacological treatment, smoking, hyposalivation and
dental restorations [3,6]. Poor oral hygiene is a negative prognostic factor, regardless of other concurrent
conditions, thus an adequate plaque control and removal of microbial biofilm is the essential therapeutic
measure to adopt in gingivitis management [3,7]. The non-surgical periodontal treatment is based on
mechanical debridement, i.e., root plaining and scaling, eventually implemented with antibacterial
and antiseptic adjuvants, such as triclosan, locally administrated tetracyclines and chlorhexidine
(CHX) [8–10]. Other chemical agents had been proven to be e↵ective in reducing subgingival bacteria
presence and activity, including thymol, xylitol and sodium fluoride [11,12]. CHX is one of the
most widely used antiseptics, mainly employed for skin and mucosa disinfection, active against
Gram-positive and Gram-negative bacteria, capsulated virus and fungi. CHX digluconate-added
mouthwashes, oral gels and toothpastes are available as home-based anti-plaque tools. This study
evaluated the e↵ect of the daily use of an oral brush-on gel containing CHX digluconate (0.2%),
xylitol and sodium fluoride (0.2% NaF) on plaque index and gingival index in patients a↵ected by
dental plaque-induced gingivitis.
2. Materials and Methods
A non-probability consecutive sampling procedure was used within 12 weeks, from January to
March 2018, among patients attending a dental clinic in Rome (Italy) with a diagnosis of plaque-induced
gingivitis, according to the American Academy of Periodontology (AAP) guidelines [2]. The sample size
was estimated using a finite population correction (FPC) considering the Lazio population with a mean
age assimilable to our sample and a gingivitis prevalence of 20%, according to AAP 2017 workshop
data [2].
Each patient underwent an anamnestic and clinical examination after signing an informed consent
to study participation. The study was conducted in accordance with the Declaration of Helsinki of
1975 and was approved by the local Ethical Committee (prot. nr. 1216/19). The exclusion criteria were
pregnancy, presence of hematologic pathologies, current anticoagulant therapy, presence of diagnosed
autoimmune gum diseases and refusal of study participation.
All patients’ full mouth plaque score (FMPS) and gingival index (GI) [13] were measured and
recorded at the first visit (t0). FMPS was performed by applying a fluorescein plaque detector and using
VALO LED curing light, according to the Dental Biofilm Detection Topographic Technique (D-Biotech)
protocol, in order to achieve a more accurate and ergonomic deplaquing. Patients were randomly
divided into a study group and a control group; both received full mouth scaling and were educated as
concerns a home oral hygiene method based on the Tailored Brushing Method (TBM) [14]. The study
group received indication to brush their teeth once a day without time specification using a full brush
(1 cm, approx. 0.5 g) dental gel with chlorhexidine digluconate (0.2%) (Cervitec Gel, Ivoclar Vivadent,
Schaan-Liechtestein), and to avoid drinking and eating for at least 30 minutes after the application,
while the control group were provided with a chlorhexidine-free gel (placebo). Both gels contained
sodium fluoride (0.2%). The two gels were identical in taste, color and texture. Neither the researcher
nor the patients were aware of the group allocation.
Every patient was asked to not use any kind of other toothpaste or mouthrinse and was told to
report any adverse e↵ect.
FMPS and GI were measured after 1 week (t1), 2 weeks (t2) and 3 weeks (t3) by the same
operator (GMN).
Statistical Analysis
The two groups’ demographical data were compared using chi-square test, while the groups’
FMPS and GI values at t0, t1, t2 and t3 were compared using a t-Student test, with statistical significance
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set at <0.05. A two-tailed Mann–Whitney test was employed to evaluate the statistical significance of
the FMPS and GI values’ di↵erence from t0 to t3 within both groups.
3. Results
In total, 30 patients were enrolled, 17 females and 13 males, with a mean age of 48 years (SD: ±
14): 15 referred to the study group and 15 to the control group. In total, six patients dropped out: three
patients from the study group did not attend the follow-up visits, one patient from the control group
missed the follow-ups and two patients from the control group did not adhere to the study protocol,
and therefore were excluded from the study. The patients’ enrollment flowchart is shown in Figure 1.
The study and the control group were statistically comparable for demographical data, such as for
baseline FMPS and GI (p > 0.05). The study group showed an FMPS improvement of 87% (p < 0.05)
and a GI decrease of 84% (p < 0.05), while the control group showed an FMPS and GI decrease of 75%
(p < 0.05) and 80% (p < 0.05), respectively.
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Figure 1. Flow-chart of the study enrollment.
Both the study and the control group showed a statistically significant reduction (p < 0.03) of
FMPS and GI indexes from t0 to t3 (Table 1).
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Table 1. Full mouth plaque score (FMPS) and Gingival index (GI) reduction from t0 to t3 in study and
control groups.
Group n. Patients Decrease t0–t3 (%) p Value
FMPS StudyControl
12
12
87%
75%
0.03 *
0.03 *
GI StudyControl
12
12
84%
80%
0.03 *
0.03 *
* Statistically significant (p < 0.05).
No statistically significant di↵erences between the clinical indexes of the two groups emerged at
t1, t2 or t3, while the FMPS index improvement (D(t0–t3)) appeared to be significantly better in the
study group (Table 2)
Table 2. Comparison of clinical indexes for test group and control group.
Patients Plaque Score (Means) Gingival Index (Means)
n Mean Age sex t0 t1 t2 t3 D(t0–t3) t0 t1 t2 t3 D(t0–t3)
Study group 12 50 F = 7M = 5
2.11
SD = 0.6
1.09
SD = 0.3
0.63
SD = 0.2
0.31
SD = 0.1
1.83
SD = 0.5
1.6
SD = 0.5
0.9
SD = 0.3
0.54
SD = 0.2
0.26
SD = 0.1
1.34
SD = 0.4
Control group 12 46 F = 6M = 6
1.16
SD = 0.5
0.58
SD = 0.4
0.46
SD = 0.4
0.48
SD = 0.3
0.87
SD = 0.3
1.87
SD = 1.1
1.46
SD = 1.4
0.87
SD = 0.5
0.68
SD = 0.5
1.17
SD = 0.6
p value 0.21 0.68 0.16 0.5 0.5 0.42 0.049 0.13 0.34 0.48 0.29 0.17
In bold the significant values. SD: Standard deviation.
The study and control group outcomes are summarized in Table 2. None of the patients reported
adverse events or side e↵ects during the study.
4. Discussion
Plaque-related gingivitis is the most common infective oral disease together with caries [15];
its proper treatment and management is crucial in the prevention of chronic periodontitis, which is the
main cause of tooth loss, with negative consequences on life quality and global health [16].
This study highlighted the value of a CHX gel as an adjuvant treatment for patients following
non-surgical periodontal treatment. Patients who applied the gel daily ended up with larger
improvements of both FMPS and GI, compared with the control group.
The FMPS underwent a greater and quicker improvement from the first week of use, while the
GI decrease required more time. This is probably due to the character of the indexes: in fact, the GI
is a tissue inflammation parameter, valuing the degree of gingival injury, and therefore the gingival
epithelium restoration can only happen after the removal of the irritative bacterial trigger. In addition,
GI is more easily a↵ected by individual factors, like gingival biotype, age, smoking and teething [3].
The plaque accumulation’s removal and control are essential for a successful periodontal disease
therapy, and professional oral hygiene instructions are proven to boost the gingival inflammation
indexes [17]. The utility of additional chemical anti-plaque agents for gingivitis treatment is
acknowledged [18], and the active substance delivery format is relevant to the patient needs
and compliance. The use of CHX mouthwashes appears to be more e↵ective than toothpastes,
while, when compared to gel and varnish, mouthwashes were less powerful in plaque control [19].
The gel ensures a longer-term release and antibacterial activity of CHX, while fluid formulation only
demonstrated a short-term e↵ect [19]. This is probably due to the higher control that the patient has
over the gel application, which allows them to perfectly dose the amount of gel needed in every site
and guarantees that the CHX contained in the product reaches all the desired areas, while liquid
textures are less controllable. Moreover, the gel can stay longer on the gums, since the patients were
asked to avoid drinks, food and rinses for at least 30 minutes after application, while mouthwashes are
generally kept in the mouth only for a few minutes and often rinsed with water.
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The brush-on application of CHX brings the benefit of a lower risk of teeth discoloration, which is
the main side e↵ect of this antiseptic compared to mouthwashes [20], other than the easier compliance
for the patients, requiring a gesture similar to teeth brushing.
The synergy with the xylitol contained in the gel formulation allows an enhancing of the
anti-inflammatory and anti-bacterial e↵ects, thanks to xylitol’s inhibition of cytokines release,
bacteria attachment and Nitric Oxide (NO) production [12,21].
The e cacy of this kind of domiciliary protocol has already been demonstrated in the elderly,
who are at higher risk of periodontal infective pathology development, and in patients a↵ected by
peri-implant mucositis [22,23].
5. Conclusions
From this study, the combination of professional mechanical debridement, which remains the gold
standard, with a home self-applied CHX gel proved to be useful in improving the clinical parameters for
patients a↵ected by plaque-induced gingivitis. Further studies are needed in order to better investigate
the long-term e↵ects of this chemical adjuvant and its e cacy in preventing periodontal diseases.
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